| Manufacturer | Atco Laboratories Pakistan |
| Active Ingredients | Colistimethate Sodium |
| Medicine Strength | 1 Million International Units per vial |
| Formulation | Powder for Solution for Intravenous/Inhalation Use |
| Requires Prescription? | Yes (Hospital/Critical Care use only) |
| Generics | Colistimethate Sodium |
Colimate Ingredients and Usage
The active ingredient is Colistimethate Sodium, a polymyxin E antibiotic. The 1 MIU powder requires reconstitution for intravenous infusion or nebulizer administration.
Colimate is clinically indicated for:
Multidrug-resistant Pseudomonas aeruginosa infections
Carbapenem-resistant Enterobacteriaceae infections
Ventilator-associated pneumonia treatment
Cystic fibrosis pulmonary exacerbations
How Does Colimate Work?
Colimate provides bactericidal action through membrane disruption:
Membrane Permeabilization: Binds to bacterial outer membrane lipopolysaccharides
Cellular Content Leakage: Causes osmotic imbalance and cell death
Rapid Bacterial Killing: Exhibits concentration-dependent killing
Biofilm Penetration: Effective against biofilm-forming bacteria
Colimate Side Effects and Warnings
Common side effects include nephrotoxicity, neurotoxicity, and bronchospasm during inhalation. Most effects are dose-dependent and reversible.
Serious Considerations
Nephrotoxicity: Requires frequent renal function monitoring
Neuromuscular Blockade: May cause respiratory muscle weakness
Dosing Calculation: Based on ideal body weight and renal function
Drug Interactions: Enhanced toxicity with aminoglycosides
Loading Dose: Essential for achieving therapeutic levels quickly
Colimate Storage Conditions
Colimate Injection requires proper storage handling:
Store below 25°C protected from light
Use reconstituted solution within 24 hours if refrigerated
Protect from moisture and freezing
Discard if solution appears discolored or contains particles
Follow strict aseptic preparation techniques
No reviews yet. Be the first to review this product!
Login to write a review